By Josh White
Date: Tuesday 05 May 2026
(Sharecast News) - Pfizer reported stronger-than-expected first-quarter results on Tuesday and reaffirmed its full-year guidance, as growth from older blockbusters and recently launched or acquired medicines offset another sharp fall in Covid product sales.
| Patent Woes Threaten Drug Firms | 07-Mar-2011 | New York Times |
| Stocks push higher on deals and strong earnings | 09-Feb-2011 | USA Today |
| Dow soars to close above 12,000 | 02-Feb-2011 | Wall Street Journal |
| Pfizer To Close UK Plant And Axe 2,400 Jobs | 01-Feb-2011 | Sky News |
| Despite good earnings reports, stocks tumble | 21-Oct-2009 | Wall Street Journal |
| Currency | US Dollars |
| Share Price | $ 27.79 |
| Change Today | $ -0.45 |
| % Change | -1.59 % |
| 52 Week High | $28.55 |
| 52 Week Low | $23.60 |
| Volume | 29,297,031 |
| Shares Issued | 5,686m |
| Market Cap | $158,014m |
| RiskGrade | 102 |
| Time | Volume / Share Price |
| 16:03 | 3,772,391 @ $27.79 |
| 15:59 | 1,272 @ $27.81 |
| 15:59 | 146 @ $27.81 |
| 15:59 | 3,300 @ $27.81 |
| 15:59 | 600 @ $27.82 |
You are here: research